PART 2 | CLEARED STATUS AND NEGATIVE RESULTS |
| Meaning of “cleared status (general)” |
| 6.—(1) For the purposes of these Regulations, an individual is treated as having a cleared status (general) only if he or she is and to the extent certified by the Director under this regulation as having a cleared status (general). [S 590/2021 wef 10/08/2021] (2) Where the Director or a recognised medical practitioner is satisfied that an individual is a recovered individual, the Director or recognised medical practitioner (as the case may be) may grant a certificate stating that the individual has a cleared status (general) for a period —| (a) | for a recovered individual who was never vaccinated against a COVID-19 infection before he or she was diagnosed as having the COVID‑19 infection —| (i) | starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing a polymerase chain reaction test (whether before, on or after 24 April 2021); and | | (ii) | ending on (and including) the 270th day after the date in sub‑paragraph (i); or |
[S 590/2021 wef 10/08/2021] | | (b) | for a recovered individual who is diagnosed as having a COVID‑19 infection after a certificate under this paragraph had been granted in respect of the individual, and who was never vaccinated against a COVID‑19 infection, the period falling after the grant of the certificate —| (i) | starting the date the recovered individual first tested positive for SARS‑CoV‑2 upon undergoing a polymerase chain reaction test leading to the diagnosis of the individual having that infection; and | | (ii) | ending on (and including) the 270th day after the date in sub‑paragraph (i). |
[S 590/2021 wef 10/08/2021] |
|
(3) Where the Director is satisfied that —| (a) | an individual is a recovered individual; | | (b) | the individual is vaccinated against a COVID-19 infection by the administration of any approved vaccine by a recognised vaccination provider; and | | (c) | 14 days or more have elapsed after the day the individual was so vaccinated, |
| the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule. |
|
(4) In addition, where the Director is satisfied that —| (a) | the individual (who is not a recovered individual) is vaccinated against a COVID‑19 infection by the administration of any approved vaccine by a recognised vaccination provider; and | | (b) | 14 days or more have elapsed after the day the individual was so vaccinated, |
| the Director may grant a certificate stating that an individual has a cleared status (general) for a period that starts and ends as stated opposite the approved vaccine in the First Schedule. |
|
(5) Despite paragraph (2), (3) or (4), where an individual is diagnosed as having a COVID-19 infection, after he or she is —| (a) | vaccinated against the COVID-19 infection; and | | (b) | granted a certificate under paragraph (3) or (4), |
| then the Director or a recognised medical practitioner may, where satisfied that the individual is a recovered individual after that infection or any later infection, grant a certificate stating that the individual has a cleared status (general) for the period — |
| (c) | starting the date the recovered individual first tested positive for SARS-CoV-2 upon undergoing a polymerase chain reaction test leading to the diagnosis of the individual having the last infection he or she recovered from; and | | (d) | ending on (and including) —| (i) | the 270th day after the date in sub-paragraph (c); or | | (ii) | the day the period referred to in and applicable to the individual under paragraph (3) or (4) would have ended if the individual had not been diagnosed as having a COVID-19 infection, |
|
[S 590/2021 wef 10/08/2021] |
(6) The Director may cancel any certificate granted under this regulation stating that an individual has a cleared status (general) if —| (a) | before the end of the period specified in paragraph (2), or referred to in paragraph (3), (4) or (5), as the case may be, and applicable to the individual —| (i) | the individual undergoes an approved test that is a polymerase chain reaction test; and | | (ii) | the individual’s test result shows the presence of SARS-CoV-2 in that individual and that is not an atypical finding for SARS-CoV-2; or |
| | (b) | the Director is satisfied that it is the interest of the health and safety of the individual to do so. |
[S 590/2021 wef 10/08/2021] |
| (7) To avoid doubt, the period in paragraph (3), (4) or (5) may be a period before 24 April 2021. [S 590/2021 wef 10/08/2021] |
|
| Meaning of “cleared status (limited)” |
| 7.—(1) For the purposes of these Regulations, an individual is treated as having a cleared status (limited) only if he or she is and to the extent certified in accordance with this regulation as having a cleared status (limited). [S 590/2021 wef 10/08/2021] (2) Where the Director or a recognised medical practitioner is satisfied that an individual (who is not a recovered individual) —| (a) | has registered, in person, with an approved test provider to undergo any approved test or tests; | | (b) | undergoes the approved test or tests; and | | (c) | has met one of the following conditions:| (i) | where the individual undergoes an approved test or tests that do not involve any polymerase chain reaction test — the individual’s test result is negative for SARS‑CoV‑2 after undergoing a relevant sampling activity for the antigen rapid test, or the last antigen rapid test if there are more than one; | | (ii) | where the individual undergoes an approved test or tests that involve one or more polymerase chain reaction tests — the individual’s test result is negative for SARS-CoV-2 after undergoing a relevant sampling activity for the polymerase chain reaction test, or the last polymerase chain reaction test if there are more than one, |
|
| the Director or recognised medical practitioner (as the case may be) may grant a certificate stating that the individual has a cleared status (limited) — |
| (d) | starting the time the individual registered, in person, with the approved test provider to undergo the approved test the test result of which shows negative for SARS-CoV-2; and | | (e) | ending 24 hours after the time in sub‑paragraph (d). |
|
| (3) To avoid doubt, the period in paragraph (2) may be a period before 24 April 2021. |
(4) The Director may cancel any certificate granted under this regulation stating that an individual has a cleared status (limited) if —| (a) | before the end of the period specified in and applicable to the individual under paragraph (2)(d) and (e) —| (i) | the individual undergoes an approved test that is a polymerase chain reaction test; and | | (ii) | the individual’s test result shows the presence of SARS-CoV-2 in that individual and that is not an atypical finding for SARS-CoV-2; or |
| | (b) | the Director is satisfied that it is the interest of the health and safety of the individual to do so. |
[S 590/2021 wef 10/08/2021] |
|
| What is negative test result |
8.—(1) For the purposes of these Regulations, where an individual undergoes an approved test or tests consisting only of a polymerase chain reaction test or tests, the individual’s test result is treated as negative for SARS-CoV-2 only if —| (a) | the test result from the sole polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual or the individual’s test result shows the presence of SARS-CoV-2 in that individual but it is an atypical finding for SARS-CoV-2; or [S 590/2021 wef 10/08/2021] | | (b) | the test result from the last polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual, after the individual undergoes further polymerase chain reaction tests and the test results of those tests are uncertain or invalid except the last, or the individual’s last test result shows the presence of SARS-CoV-2 in that individual but it is an atypical finding for SARS-CoV-2. [S 590/2021 wef 10/08/2021] |
(2) For the purposes of these Regulations, where an individual undergoes an approved test or tests consisting only of an antigen rapid test or tests, the individual’s test result is treated as negative for SARS‑CoV‑2 only if —| (a) | the antigen rapid test result from the sole antigen rapid test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual; or | | (b) | the test result from the last antigen rapid test the individual undergoes shows no presence of SARS‑CoV‑2 in that individual, after the individual undergoes further antigen rapid tests and the test results of those tests are uncertain or invalid except the last. [S 768/2021 wef 11/10/2021] |
|
(3) For the purposes of these Regulations, where an individual undergoes a series of approved tests consisting of polymerase chain reaction tests and antigen rapid tests, the individual’s test result is treated as negative for SARS‑CoV-2 only if —| (a) | the test results of the antigen rapid tests are uncertain or invalid, another respiratory specimen from the individual is then subjected to a polymerase chain reaction test, and —| (i) | the test result from that polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV-2 in that individual or the individual’s test result shows the presence of SARS-CoV-2 in that individual but it is an atypical finding for SARS-CoV-2; or [S 590/2021 wef 10/08/2021] | | (ii) | the test result from the last polymerase chain reaction test the individual undergoes shows no presence of SARS-CoV-2 in that individual, after the individual undergoes further polymerase chain reaction tests and the test results of those tests are uncertain or invalid except the last, or the individual’s last test result shows the presence of SARS-CoV-2 in that individual but it is an atypical finding for SARS-CoV-2; or [S 590/2021 wef 10/08/2021] |
[S 768/2021 wef 11/10/2021] | | (b) | the test result of an antigen rapid test shows the presence of SARS‑CoV-2 in that individual, another respiratory specimen from the individual is then subjected to a polymerase chain reaction test, and —| (i) | the test result from that polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV-2 in that individual or the individual’s test result shows the presence of SARS-CoV-2 in that individual but it is an atypical finding for SARS-CoV-2; or [S 590/2021 wef 10/08/2021] | | (ii) | the test result from the last polymerase chain reaction test the individual undergoes shows no presence of SARS‑CoV-2 in that individual, after the individual undergoes further polymerase chain reaction tests and the test results of those tests are uncertain or invalid except the last, or the individual’s last test result shows the presence of SARS-CoV-2 in that individual but it is an atypical finding for SARS-CoV-2. [S 590/2021 wef 10/08/2021] |
|
|
(4) Despite paragraphs (1), (2) and (3), a result of an antigen rapid test for the presence of SARS‑CoV-2 applied to an individual’s respiratory specimen must be disregarded for the purposes of these Regulations if —| (a) | the relevant sampling activity taking the respiratory specimen from the individual was —| (i) | not performed in Singapore, or not performed by or under the direction of an approved test provider where the relevant sampling activity is not self-administered; or | | (ii) | in the case of a self-administered relevant sampling activity performed by the individual on himself or herself, not supervised by an approved test provider; or |
[S 768/2021 wef 11/10/2021] | | (b) | the relevant testing activity or the relevant assessment activity involving the respiratory specimen from the individual was —| (i) | not performed in Singapore, or not performed by or under the direction of an approved test provider where the relevant testing activity or the relevant assessment activity is not self-administered; or | | (ii) | in the case of a self-administered relevant testing activity or a self-administered relevant assessment activity performed by the individual involving the respiratory specimen removed from himself or herself, not supervised by an approved test provider. |
[S 768/2021 wef 11/10/2021] |
|
|
| When is cleared status current |
8A.—(1) For the purposes of these Regulations, an individual who has a cleared status (general) because he or she is granted a certificate under regulation 6(2) does not have a cleared status (general) that is current —| (a) | after the end of the period specified in and applicable to the individual under regulation 6(2); | | (b) | during any suspended status interval, even if that interval lies within the period specified in and applicable to the individual under regulation 6(2); or | | (c) | after the certificate under regulation 6(2) is cancelled. |
(2) For the purposes of these Regulations, an individual who has a cleared status (general) because he or she is granted a certificate under regulation 6(3), (4) or (5) does not have a cleared status (general) that is current —| (a) | after the end of the period referred to in and applicable to the individual under regulation 6(3), (4) or (5), as the case may be; | | (b) | during any suspended status interval, even if that interval lies within the period referred to in and applicable to the individual under regulation 6(3), (4) or (5); or | | (c) | after the cancellation of the certificate under regulation 6(3), (4) or (5), as the case may be. |
|
(3) For the purposes of these Regulations, an individual who has a cleared status (limited) because he or she is granted a certificate under regulation 7(2), does not have a cleared status (limited) that is current —| (a) | after the end of the period specified in and applicable to the individual under regulation 7(2); | | (b) | during any suspended status interval where any part of that interval lies within the period referred to in and applicable to the individual under regulation 7(2); or | | (c) | after the certificate under regulation 7(2) is cancelled. |
|
(4) In this regulation, a suspended status interval for an individual granted a certificate under regulation 6(2), (3), (4) or (5) or 7(2), means any of the following periods falling after the grant of that certificate:| (a) | the period that he or she is subject to a movement control measure; [S 682/2021 wef 08/09/2021] | | (b) | the period —| (i) | starting the time (not date) the individual first tests positive for SARS-CoV-2 upon undergoing a polymerase chain reaction test; and | | (ii) | ending on (and including) the day those test results are determined to be an atypical finding for SARS‑CoV‑2; |
| | (c) | [Deleted by S 682/2021 wef 08/09/2021] | | (d) | the period —| (i) | starting the time (not date) the individual undergoes any approved test that is an antigen rapid test (or the first of any such approved tests if there is more than one) where the test result of the antigen rapid test shows the presence of SARS-CoV-2 in that individual; and | | (ii) | ending —| (A) | on (and including) the 10th day after the date of the approved test (or of the first approved test, as the case may be) mentioned in sub-paragraph (i); | | (B) | the time (not date) the individual’s test result after undergoing a polymerase chain reaction test, is treated as negative for SARS-CoV-2 or an atypical finding for SARS-CoV-2; or | | (C) | the time (not date) the individual’s test result is treated as negative for SARS-COV-2 after the individual undergoes an approved test that is an antigen rapid test where the relevant sampling activity for the antigen rapid test is performed at least 72 hours after the time in sub-paragraph (i), |
|
[S 768/2021 wef 11/10/2021] | | (e) | [Deleted by S 768/2021 wef 11/10/2021] |
|
(5) For the purposes of paragraph (4), a movement control measure, in relation to an individual, means a requirement for the individual not to leave a place of accommodation because of —| (a) | an order made under regulation 3(1) of the Infectious Diseases (COVID-19 — Stay Orders) Regulations 2020 (G.N. No. S 182/2020); | | (b) | regulation 3(2) of the Infectious Diseases (COVID-19 — Stay Orders) Regulations 2020; or | | (c) | an order under section 15 or 17 of the Act. |
|
[S 590/2021 wef 10/08/2021] |
|